KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioNTech SE (BNTX) Goodwill (2018 - 2025)

Historic Goodwill for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to $418.2 million.

  • BioNTech SE's Goodwill rose 181.06% to $418.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $418.2 million, marking a year-over-year increase of 181.06%. This contributed to the annual value of $406.7 million for FY2024, which is 427.64% up from last year.
  • Per BioNTech SE's latest filing, its Goodwill stood at $418.2 million for Q3 2025, which was up 181.06% from $412.1 million recorded in Q2 2025.
  • Over the past 5 years, BioNTech SE's Goodwill peaked at $418.2 million during Q3 2025, and registered a low of $62.4 million during Q4 2022.
  • Its 5-year average for Goodwill is $341.9 million, with a median of $400.5 million in 2024.
  • As far as peak fluctuations go, BioNTech SE's Goodwill tumbled by 556.91% in 2022, and later soared by 52465.35% in 2023.
  • BioNTech SE's Goodwill (Quarter) stood at $66.1 million in 2021, then dropped by 5.57% to $62.4 million in 2022, then soared by 524.65% to $390.0 million in 2023, then increased by 4.28% to $406.7 million in 2024, then grew by 2.82% to $418.2 million in 2025.
  • Its last three reported values are $418.2 million in Q3 2025, $412.1 million for Q2 2025, and $395.4 million during Q1 2025.